Jim Cramer's Stop Trading! SunTrust Shines

Monday's huge European banking deal makes SunTrust (STI Quote), Fifth Third (FITB Quote) and Comerica (CMA Quote) "worth a look," Jim Cramer said on CNBC's "Stop Trading!" segment.

Cramer said the $91 billion linkup of Barclays (BCS Quote) and ABN Amro (ABN Quote) warrants a review of possible buyout candidates among the midtier U.S. bankers. Cramer also said he wishes Bank of America (BAC Quote), fresh off Monday's $21 billion buy of ABN's LaSalle unit, "would spend a couple days not acquiring something." He said he believes the bank is "addicted" to deals, and he warns that "there is no 12-step program for what Bank of America is doing."

Cramer also is taking another look at Celgene (CELG Quote) and Cephalon (CEPH Quote) in the wake of Monday's $16 billion tie-up between AstraZeneca (AZN Quote) and Medimmune (MEDI Quote). Cramer said the deal, at first blush a case of massive overpayment on the part of AstraZeneca, could prompt a "radical revaluation" of rivals Celgene and Cephalon, which could turn out to be "way undervalued" by the Medimmune standard.

Cramer is less taken by GM's (GM Quote) claim that its sales are being hit by the mortgage meltdown. Cramer notes that retail sales have remained robust, and he believes that the rising price of gasoline may be further depressing sales of the sport utility vehicles that GM and Ford (F Quote) have been pitching to the exclusion of all else in recent years.